Professor, chief physician, doctor of medicine, director of Nephropathy and Diabetes Center of Beijing Hospital of Integrated Traditional Chinese and Western Medicine, tutor of clinical (nephrosis) master students of integrated traditional Chinese and western medicine, graduated from Beijing University of Chinese Medicine, majoring in basic immunology of integrated traditional Chinese and western medicine, working for 265,438+0 years, mainly engaged in kidney disease of integrated traditional Chinese and western medicine for 65,438+05 years. He studied under Professor Du, a clinical nephrologist in China, former president of Shaanxi College of Traditional Chinese Medicine, and an immunologist in China. He studied kidney disease, hemodialysis technology and animal experiment technology in tongji hospital and peking university health science center successively. Mainly engaged in the research of treating and delaying the progress of chronic renal failure with integrated traditional Chinese and western medicine, the material basis of the curative effect of traditional Chinese medicine on glomerular diseases, the dialectical law of traditional Chinese medicine in treating glomerular diseases, and the clinical application research of blood purification technology, such as maintenance hemodialysis, rescue of severe heart failure, drug poisoning, organophosphorus poisoning, refractory ascites reinfusion, etc. The combination of traditional Chinese and western medicine is used to treat and delay chronic renal failure from entering dialysis stage, and the combination of traditional Chinese and western medicine to treat nephrotic syndrome, chronic nephritis, lupus kidney, henoch-schonlein purpura kidney and diabetic complications is the main specialty. Through the observation of nearly 50 uremic patients with chronic renal failure, it is found that the empirical formula Tongluo Baoshen Compound has a positive effect. Most patients took Tongluo Bushen compound combined with modern medical comprehensive treatment, and their condition was stable for more than one and a half years, so they did not enter dialysis treatment. At present, he is the tutor of master students majoring in clinical (nephrosis) of integrated traditional Chinese and western medicine in Beijing University of Chinese Medicine, the expert evaluation member of traditional Chinese medicine disciplines of the National Natural Fund: nephrosis of traditional Chinese medicine and immunopharmacology of traditional Chinese medicine, the invited reviewer of many domestic magazines such as China-Japan Friendship Hospital Magazine, the "125" talent in Beijing, the member of Beijing Branch of China Society of Traditional Chinese Medicine, the member of Beijing Branch of China Society of Integrated Traditional Chinese and Western Medicine and the member of Beijing Branch of Chinese Medical Association. As the main finisher of the project, he participated in the research of "New Drugs for Rheumatoid Arthritis Ⅱ with Total Glucosides of Cornus officinalis" funded by the New Drugs Fund of the State Science and Technology Commission, and participated in the research of "Sjogren's Syndrome Model Making and Pathogenesis Research of Deficiency of both Qi and Yin" funded by the state administration of traditional chinese medicine Traditional Chinese Medicine Research Fund. As the project leader, he presided over the research on the molecular mechanism of kidney collateral stasis (renal fibrosis) and the intervention effect of traditional Chinese medicine funded by Beijing Science and Technology Development Fund of Traditional Chinese Medicine. Participated in the National Tenth Five-Year Plan Project hosted by Professor Chen Xiangmei from the Department of Nephrology, General Hospital of Chinese People's Liberation Army: Study on Pathological Changes of IgA Nephropathy and the Law of TCM Syndrome Differentiation and Treatment. At present, a total of 8 papers/kloc-0 have been published, and the chief editor is 1 department.